Fingerprint
Dive into the research topics of 'Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer
K. J. O'Byrne, N. Dobbs, D. J. Propper, J. P. Braybrooke, M. I. Koukourakis, K. Mitchel, J. Woodhull, D. C. Talbot, A. V. Schally, A. L. Harris
Research output: Contribution to journal › Article › peer-review
33
Scopus
citations